Centre for Cancer Research

Kidney cancer publications

2009
Lane BR, Li J, Zhou M, Babineau D, Faber P, Novick AC, Williams BRG (2009) Differential expression in clear cell renal cell carcinoma identified by gene expression profiling. J Urol 181:849-860.

2008
Gupta A, Kessler P, Rawwas J, Williams BRG (2008) Regulation of CRABP-II expression by MycN in Wilms tumor. Exp Cell Res 314:3663-3668.


2006
Graham K, Li W, Williams BRG and Fraizer G (2006) Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells. Gene Expr 13:1-14.

Holko M and Williams BRG (2006) Functional annotation of IFN-α-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines. J Interferon Cytokine Res 26:534-547.
Supplementary figure

2005
Li W, Kessler P and Williams BRG (2005) Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia. Oncogene 24:457-458.

Li W, Kessler P, Yeger H, Alami J, Reeve AE, Heathcott R, Skeen J and Williams BRG  (2005) A gene expression signature for relapse of primary Wilms tumors. Cancer Res 65:2592-2601.

2004
Jackson MW, Agarwal MK, Agarwal ML, Agarwal A, Stanhope-Baker P, Williams BRG and Stark GR (2004) Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.  Oncogene 23:4477-4487.

Stanhope-Baker P, Kessler PM, Li W, Agarwal ML and Williams BRG (2004) The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. J Biol Chem 279:33575-33585.

2003
Alami J, Williams BR and Yeger H (2003) Differential expression of E-cadherin and β-catenin in primary and metastatic Wilms’s tumours. J Clin Pathol: Mol Pathol 56:218-225.

Alami J, Williams BR and Yeger H (2003) Derivation and characterization of a Wilms’ tumour cell line, WiT 49. Int J Cancer 107:365-374.

Feinberg AP and Williams BRG (2003) Wilms’ tumor as a model for cancer biology. Meth Mol Biol 222:239-248.